Updated results of the FOENIX-CCA2 trial: Efficacy and safety of futibatinib in intrahepatic cholangiocarcinoma harboring FGFR2 fusions/rearrangements.

Trifluridine/tipiracil plus bevacizumab and trifluridine/tipiracil monotherapy in metastatic colorectal cancer: Results of a meta-analysis

Study protocol of an open-label, single arm, phase II trial investigating the efficacy and safety of trifluridine/tipiracil combined with irinotecan as a second line therapy in patients with cholangiocarcinoma (TRITICC).